Hydroxybutyrate Dehydrogenase
"Hydroxybutyrate Dehydrogenase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D006884
|
MeSH Number(s) |
D08.811.682.047.820.350
|
Concept/Terms |
Hydroxybutyrate Dehydrogenase- Hydroxybutyrate Dehydrogenase
- Dehydrogenase, Hydroxybutyrate
- D-3-Hydroxybutyrate Dehydrogenase
- D 3 Hydroxybutyrate Dehydrogenase
- Dehydrogenase, D-3-Hydroxybutyrate
- D-beta-Hydroxybutyrate Dehydrogenase
- D beta Hydroxybutyrate Dehydrogenase
- Dehydrogenase, D-beta-Hydroxybutyrate
- 3-Hydroxybutyrate Dehydrogenase
- 3 Hydroxybutyrate Dehydrogenase
- Dehydrogenase, 3-Hydroxybutyrate
|
Below are MeSH descriptors whose meaning is more general than "Hydroxybutyrate Dehydrogenase".
Below are MeSH descriptors whose meaning is more specific than "Hydroxybutyrate Dehydrogenase".
This graph shows the total number of publications written about "Hydroxybutyrate Dehydrogenase" by people in this website by year, and whether "Hydroxybutyrate Dehydrogenase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hydroxybutyrate Dehydrogenase" by people in Profiles.
-
Features of a-HBDH in COVID-19 patients: A cohort study. J Clin Lab Anal. 2021 Jan; 35(1):e23690.
-
Elevated a-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19. ESC Heart Fail. 2021 02; 8(1):644-651.
-
Clinical features, laboratory findings and persistence of virus in 10 children with coronavirus disease 2019 (COVID-19). Biomed J. 2021 Mar; 44(1):94-100.
-
Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series. PLoS Med. 2020 06; 17(6):e1003130.
-
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study. Clin Microbiol Infect. 2020 Sep; 26(9):1242-1247.
-
Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases. Dig Liver Dis. 2020 10; 52(10):1076-1079.